Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 17;12(20):e031874.
doi: 10.1161/JAHA.123.031874. Epub 2023 Oct 10.

Optimizing Transcatheter Edge-to-Edge Repair of the Mitral Valve: The Relentless Pursuit of Perfection

Amar Krishnaswamy  1 , Rhonda Miyasaka  1
Affiliations
Editorial

Optimizing Transcatheter Edge-to-Edge Repair of the Mitral Valve: The Relentless Pursuit of Perfection

Amar Krishnaswamy et al. J Am Heart Assoc. .
No abstract available

Keywords: 3D MPR; Editorials; mitral valve repair; multiplanar reconstruction.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Factors that contribute to an optimal mitral transcatheter edge‐to‐edge repair (TEER).
MR indicates mitral regurgitation; and MV, mitral valve.
Figure 2
Figure 2. Pre‐ and intraprocedural transesophageal echocardiographic imaging using 3‐dimensional multiplanar reconstruction (3D MPR).
The detail provided by MPR imaging and versatility of the current generation device allows a granular analysis of the result and further optimization (for example, the residual MR seen lateral to the clip at the posterior leaflet in panel 4 is treated by lifting the posterior gripper and slight clockwise rotation of the clip with resolution of MR seen in panel 6). MR indicates mitral regurgitation.
See this image and copyright information in PMC

Comment on

References

    1. Kubo S, Yamamoto M, Saji M, Asami M, Enta Y, Nakashima M, Shirai S, Izumo M, Mizuno S, Watanabe Y, et al. One‐year outcomes and their relationship to residual mitral regurgitation after transcatheter edge‐to‐edge repair with MitraClip device: insights from the OCEAN‐Mitral registry. J Am Heart Assoc. 2023;12:e030747. doi: 10.1161/JAHA.123.030747 - DOI - PMC - PubMed
    1. Sorajja P, Mack M, Vemulapalli S, Holmes DR Jr, Stebbins A, Kar S, Lim DS, Thourani V, McCarthy P, Kapadia S, et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol. 2016;67:1129–1140. doi: 10.1016/j.jacc.2015.12.054 - DOI - PubMed
    1. Makkar RR, Chikwe J, Chakravarty T, Chen Q, O'Gara PT, Gillinov M, Mack MJ, Vekstein A, Patel D, Stebbins AL, et al. Transcatheter mitral valve repair for degenerative mitral regurgitation. JAMA. 2023;329:1778–1788. doi: 10.1001/jama.2023.7089 - DOI - PMC - PubMed
    1. von Bardeleben RS, Rogers JH, Mahoney P, Price MJ, Denti P, Maisano F, Rinaldi M, Rollefson WA, De Marco F, Chehab B, et al. Real‐world outcomes of fourth‐generation mitral transcatheter repair: 30‐day results from EXPAND G4. JACC Cardiovasc Interv. 2023;16:1463–1473. doi: 10.1016/j.jcin.2023.05.013 - DOI - PubMed
    1. Kar S, Mack MJ, Lindenfeld J, Abraham WT, Asch FM, Weissman NJ, Enriquez‐Sarano M, Lim DS, Mishell JM, Whisenant BK, et al. Relationship between residual mitral regurgitation and clinical and quality‐of‐life outcomes after transcatheter and medical treatments in heart failure: COAPT trial. Circulation. 2021;144:426–437. doi: 10.1161/CIRCULATIONAHA.120.053061 - DOI - PubMed

MeSH terms

LinkOut - more resources